Virtus Investment Advisers, LLC

Position in ZYME — Zymeworks Inc.

CIK 19481 HARTFORD, CT

Position in ZYME

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,328,565

+$1,060,587 QoQ

Shares Held

50,825

+374.9% QoQ

Ownership

0.072%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

#80

of 203 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Virtus Investment Advisers, LLC holds $130,556,170 across 185 Biotechnology names. ZYME ranks #23 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	29,544	$3,349,107
2	ALNY	Alnylam Pharmaceuticals, Inc.	9,953	$2,996,151
3	REGN	Regeneron Pharmaceuticals, Inc.	4,320	$2,693,692
4	MRNA	Moderna, Inc.	23,300	$1,631,699
5	RARE	Ultragenyx Pharmaceutical Inc.	47,757	$1,594,606
6	PGEN	Precigen, Inc.	261,322	$1,489,535
7	AGIO	Agios Pharmaceuticals, Inc.	39,473	$1,464,843
8	RYTM	Rhythm Pharmaceuticals, Inc.	13,158	$1,460,932

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,328,565	50,825	+374.9%	Shares	Other	2026-08-11
2026-03-31	$267,978	10,702	+2.5%	Shares	Other	2026-05-14
2025-12-31	$274,911	10,441	+20.2%	Shares	Other	2026-02-17
2025-09-30	$148,356	8,686	+21.0%	Shares	Other	2025-11-14
2025-06-30	$90,083	7,178	-44.8%	Shares	Other	2025-08-13
2025-03-31	$154,901	13,006	+32.5%	Shares	Other	2025-05-15
2024-09-30	$123,228	9,819	-42.2%	Shares	Other	2024-11-14
2024-06-30	$144,670	17,000	-69.8%	Shares	Other	2024-08-14
2024-03-31	$592,938	56,363	0.0%	Shares	Other	2024-05-16
2023-12-31	$585,611	56,363	—	Shares	Other	2024-02-15
No filing history on record for this holder in this stock.